Respiratory Complications in Patients with Severe Cases of COVID-19
Many patients with COVID-19 have been treated at Cochin Hospital, either in standard units for COVID patients or in intensive care units, depending on the severity of their respiratory symptoms. Some of these patients may experience long-term pulmonary complications. If this proves to be true, will these complications be proportional to the severity of the initial case? Professors Dinh-Xuan and Roche at Cochin Hospital will monitor the recovery of one hundred of these patients for 24 months. Their goal is to understand the mechanisms behind the evolution from initial lung damage to possible chronic illness, in order to identify risk factors and develop a prevention strategy.
|Project Initiator: Robert Debré organization for medical research||
Year(s) of support: 2020-2021
|Support provided: Measuring device for exhaled NO, dual NO/CO diffusion device, forced oscillometry devices, consumable materials and salary for a master's student for two years||Amount provided: 102,000 euros|
|Location: Cochin Hospital, Paris, France||
Air Liquide Monitoring manager:
Jean-Christophe Richard, Medical Research Director, Air Liquide Medical Systems
Acute Respiratory Distress
While the SARS-CoV-2 virus is transmitted via the upper airways (nose, nasal cavities, mouth, pharynx and larynx), a certain percentage of patients develop viral pneumonia whose severity depends on how extensive it is in the lung and the degree of respiratory failure, resulting in hypoxemia (diminished blood oxygen levels).
In the most serious cases, pneumonia-induced hypoxemia can lead to acute respiratory distress syndrome (ARDS). The medium- and long-term complications arising from this pneumonia are not known.
Given what we know about the physiopathology of COVID-19 and acute respiratory distress syndrome, it is possible that a new chronic illness linked to the coronavirus will emerge, and that a significant percentage of patients with COVID-19 may experience long-term respiratory complications, including developing chronic post-COVID respiratory failure. This percentage of patients could be as high as 25%, according to initial findings.
Monitoring Respiratory Function for Three Months
Professors Dinh-Xuan and Roche from Cochin Hospital aim to:
- identify, quantify and classify anomalies in respiratory function in patients with severe cases of COVID-19 over the 24 months following their hospitalization in intensive care units and
- study the underlying mechanisms causing these anomalies
More than 100 patients with covid-19 with respiratory disease who have been hospitalized at Cochin Hospital are being followed as part of this research. Very complete measurements of their respiratory function will be taken precisely every 3 months for 2 years after the onset of their symptoms.
The teams led by Professors Dinh-Xuan and Roche will particularly focus on airflow and volume in the lungs (spirometry) and oxygen and carbon dioxide exchanges between the air and the blood at the tissue level.
The results of this study will make it possible to better understand, explore and treat long-term respiratory complications caused by viral infections that share characteristics with COVID-19, with or without acute respiratory distress.
How the Air Liquide Foundation is participating
The Foundation enables Prof. Dinh-Xuan and Prof. Roche to carry out their research work thanks to the funding of state-of-the-art equipment, including an expired NO measuring device, and the funding of the salary of a master's student dedicated to this study for 2 years.
Discover other projects we support
Improving bedside ventilation monitoring
A portable ultrasound scanner to monitor the condition of patients in intensive care and make work easier for caregivers
Study of biomarkers of Covid-19 aggravation
Clinicians are observing a delayed worsening after 7 days in certain patients suffering from Covid-19.
Severe cases of Covid-19 developing into pulmonary fibrosis
Epidemiological and clinical data support the theory that pulmonary fibrosis may be one of the main complications in patients suffering from Covid-19.
Predicting respiratory deterioration in severe forms of COVID-19
Measuring the biomarkers of severely affected patients to predict the disease's evolution